Skip to main content
    D

    Dyne Therapeutics Inc (DYN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $16.70
    -0.46 (-2.68%)

    Market Cap: $3.22B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Dyne Therapeutics Inc (DYN) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Dyne Therapeutics are Beam Therapeutics (BEAM), Disc Medicine (IRON) and Dianthus Therapeutics (DNTH). By market cap, Dyne Therapeutics ranks 7th of the 13 companies on this page; Cytokinetics (CYTK) is the largest at $7.82B.

    Peer Comparison

    DYN's ROIC of -42.9% is below the peer median of -34.9%, and its revenue growth of 0.0% is in line with the median. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Dyne Therapeutics (DYN)$3.22BN/AN/A0.0%-42.9%0.0%0.00%
    Beam Therapeutics Inc (BEAM)$2.36BN/A15.0x-73.9%-29.7%-96.8%0.00%
    Disc Medicine Inc. (IRON)$3.64BN/AN/A0.0%-40.0%0.0%0.00%
    Dianthus Therapeutics Inc. (DNTH)$5.17BN/AN/A0.0%N/A205.6%0.00%
    Denali Therapeutics Inc (DNLI)$3.00BN/A159.3x0.0%N/A-100.0%0.00%
    Cytokinetics Inc (CYTK)$7.82BN/A65.3x0.0%-66.0%2357.0%0.00%
    Legend Biotech Corp (LEGN)$3.39B266.5x2.3x-0.0%N/A32.0%0.00%
    Xenon Pharmaceuticals Inc (XENE)$3.98BN/AN/A0.0%N/A-100.0%0.00%
    MBX Biosciences, Inc. Common Stock (MBX)$2.78BN/AN/A0.0%N/A0.0%0.00%
    Edgewise Therapeutics Inc (EWTX)$5.03BN/AN/A0.0%N/A0.0%0.00%
    Celldex Therapeutics Inc (CLDX)$2.26BN/AN/A0.0%N/A-97.0%0.00%
    Ideaya Biosciences Inc (IDYA)$3.08BN/A85.5x0.0%N/A-95.1%0.00%
    Telix Pharmaceuticals Limited (TLX)$3.14BN/A5.3x3.8%-0.7%22.3%0.00%
    Peer median$3.27B266.5x40.1x0.0%-34.9%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Dyne Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Beam Therapeutics Inc (BEAM)
    Beam Therapeutics Inc., a biotechnology company, develops precision genetic drugs for patients with serious illnesses in the United States.
    BEAM competitors
    Disc Medicine Inc. (IRON)
    Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development...
    IRON competitors
    Dianthus Therapeutics Inc. (DNTH)
    Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company that designs, develops...
    DNTH competitors
    Denali Therapeutics Inc (DNLI)
    Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States.
    DNLI competitors
    Cytokinetics Inc (CYTK)
    Cytokinetics, Incorporated, an advanced stage biopharmaceutical company, focuses on discovering...
    CYTK competitors
    Legend Biotech Corp (LEGN)
    Legend Biotech Corporation, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new cell therapies for oncology...
    LEGN competitors
    Xenon Pharmaceuticals Inc (XENE)
    Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat patients with neurological disorders...
    XENE competitors
    MBX Biosciences, Inc. Common Stock (MBX)
    MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment...
    MBX competitors
    Edgewise Therapeutics Inc (EWTX)
    Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases.
    EWTX competitors
    Celldex Therapeutics Inc (CLDX)
    Celldex Therapeutics, Inc., a biopharmaceutical company, is dedicated to the development of therapeutic monoclonal and bispecific antibodies for the treatment...
    CLDX competitors
    Ideaya Biosciences Inc (IDYA)
    IDEAYA Biosciences, Inc., a synthetic precision medicine oncology company focused on lethality...
    IDYA competitors
    Telix Pharmaceuticals Limited (TLX)
    Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic...

    Frequently Asked Questions About DYN

    Who are Dyne Therapeutics' main competitors?

    The companies most similar to Dyne Therapeutics include Beam Therapeutics (BEAM), Disc Medicine (IRON), Dianthus Therapeutics (DNTH), Denali Therapeutics (DNLI) and Cytokinetics (CYTK), listed from the closest match.

    Who is Dyne Therapeutics' biggest competitor?

    Cytokinetics (CYTK) is the largest of the similar companies at $7.82B; Beam Therapeutics (BEAM) is the closest match by business profile, size, sector and industry.

    How does DYN stock compare with its competitors?

    DYN's net margin is 0.0% against a peer median of 0.0%.

    Which of Dyne Therapeutics' competitors pays a higher dividend?

    Dyne Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Dyne Therapeutics bigger than its competitors?

    No. Dyne Therapeutics is 7th by market cap among the 13 companies on this page; the largest is Cytokinetics (CYTK) at $7.82B.